This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (144)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

Jeremiah Stamler, MD; Martha L. Daviglus, MD, PhD; Daniel B. Garside, MA; Alan R. Dyer, PhD; Philip Greenland, MD; James D. Neaton, PhD

JAMA. 2000;284:311-318.

Context  Based on observational and interventional data for middle-aged cohorts (aged 40-64 years), serum cholesterol level is known to be an established major risk factor for coronary heart disease (CHD). However, findings for younger people are limited, and the value of detecting and treating hypercholesterolemia in younger adults is debated.

Objective  To evaluate the long-term impact of unfavorable serum cholesterol levels on risk of death from CHD, cardiovascular disease (CVD), and all causes.

Design, Setting, and Participants  Three prospective studies, from which were selected 3 cohorts of younger men with baseline serum cholesterol level measurements and no history of diabetes mellitus or myocardial infarction. A total of 11,017 men aged 18 through 39 years screened in 1967-1973 for the Chicago Heart Association Detection Project in Industry (CHA); 1266 men aged 25 through 39 years examined in 1959-1963 in the Peoples Gas Company Study (PG); and 69,205 men aged 35 through 39 years screened in 1973-1975 for the Multiple Risk Factor Intervention Trial (MRFIT).

Main Outcome Measures  Cause-specific mortality during 25 (CHA), 34 (PG), and 16 (MRFIT) years of follow-up; mortality risks; and estimated life expectancy in relation to baseline serum cholesterol levels.

Results  Death due to CHD accounted for 26%, 34%, and 28% of all deaths in the CHA, PG, and MRFIT cohorts, respectively; and CVD death for 34%, 42%, and 39% of deaths in the same cohorts, respectively. Men in all 3 cohorts with unfavorable serum cholesterol levels (200-239 mg/dL [5.17-6.18 mmol/L] and 240 mg/dL [6.21 mmol/L]) had strong gradients of relative mortality risk. For men with serum cholesterol levels of 240 mg/dL or greater (6.21 mmol/L) vs favorable levels (<200 mg/dL [<5.17 mmol/L]), CHD mortality risk was 2.15 to 3.63 times greater; CVD disease mortality risk was 2.10 to 2.87 times greater; and all-cause mortality was 1.31 to1.49 times greater. Hypercholesterolemic men had age-adjusted absolute risk of CHD death of 59 per 1000 men in 25 years (CHA cohort), 90 per 1000 men in 34 years (PG cohort), and 15 per 1000 men in 16 years (MRFIT cohort). Absolute excess risk was 43.6 per 1000 men (CHA), 81.4 per 1000 men (PG), and 12.1 per 1000 men (MRFIT). Men with favorable baseline serum cholesterol levels had an estimated greater life expectancy of 3.8 to 8.7 years.

Conclusions  These results demonstrate a continuous, graded relationship of serum cholesterol level to long-term risk of CHD, CVD, and all-cause mortality, substantial absolute risk and absolute excess risk of CHD and CVD death for younger men with elevated serum cholesterol levels, and longer estimated life expectancy for younger men with favorable serum cholesterol levels.

Author Affiliations: Department of Preventive Medicine, Northwestern University Medical School, Chicago, Ill (Drs Stamler, Daviglus, Dyer, and Greenland and Mr Garside); Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (Dr Neaton).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Early Detection of High Cholesterol Levels in Young Adults
Scott M. Grundy
JAMA. 2000;284(3):365-367.
EXTRACT | FULL TEXT  

July 19, 2000
JAMA. 2000;284(3):375-376.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Endothelial Function Predicts Progression of Carotid Intima-Media Thickness
Halcox et al.
Circulation 2009;119:1005-1012.
ABSTRACT | FULL TEXT  

Traditional Clinical Risk Assessment Tools Do Not Accurately Predict Coronary Atherosclerotic Plaque Burden: A CT Angiography Study
Johnson et al.
Am. J. Roentgenol. 2009;192:235-243.
ABSTRACT | FULL TEXT  

An Assessment of the New Lipid Screening Guidelines: In Reply
Daniels et al.
Pediatrics 2008;122:906-907.
FULL TEXT  

In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry
Missel et al.
Eur Heart J 2008;29:2141-2147.
ABSTRACT | FULL TEXT  

Total Cholesterol, Severity of Stroke, and All-Cause Mortality
Sheikh
Stroke 2008;39:e61-e62.
FULL TEXT  

A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men
May et al.
Int J Epidemiol 2007;36:1309-1318.
ABSTRACT | FULL TEXT  

Primary Prevention of Coronary Artery Disease
Domanski
NEJM 2007;357:1543-1545.
FULL TEXT  

Cholesterol Fractions and Apolipoproteins as Risk Factors for Heart Disease Mortality in Older Men
Clarke et al.
Arch Intern Med 2007;167:1373-1378.
ABSTRACT | FULL TEXT  

Early Adult Risk Factor Levels and Subsequent Coronary Artery Calcification: The CARDIA Study
Loria et al.
J Am Coll Cardiol 2007;49:2013-2020.
ABSTRACT | FULL TEXT  

Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Controlled Trial
Lee et al.
JAMA 2006;296:2563-2571.
ABSTRACT | FULL TEXT  

Fiber Intakes and Anthropometric Measures are Predictors of Circulating Hormone, Triglyceride, and Cholesterol Concentrations in the Women's Health Trial
Bhargava
J. Nutr. 2006;136:2249-2254.
ABSTRACT | FULL TEXT  

Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure
Mancia et al.
Hypertension 2006;47:846-853.
ABSTRACT | FULL TEXT  

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Cohen et al.
NEJM 2006;354:1264-1272.
ABSTRACT | FULL TEXT  

Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age
Lloyd-Jones et al.
Circulation 2006;113:791-798.
ABSTRACT | FULL TEXT  

Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies
Shaw et al.
J Am Coll Cardiol 2006;47:S4-S20.
ABSTRACT | FULL TEXT  

Relationship of Office, Home, and Ambulatory Blood Pressure to Blood Glucose and Lipid Variables in the PAMELA Population
Mancia et al.
Hypertension 2005;45:1072-1077.
ABSTRACT | FULL TEXT  

Advanced Lipoprotein Testing Does Not Improve Identification of Subclinical Atherosclerosis in Young Adults: The Bogalusa Heart Study
Tzou et al.
ANN INTERN MED 2005;142:742-750.
ABSTRACT | FULL TEXT  

Aim Low
Nash
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:599-600.
FULL TEXT  

Dyslipidaemia among Indo-Asians strategies for identification and management
Enas et al.
British Journal of Diabetes & Vascular Disease 2005;5:81-90.
ABSTRACT  

A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease
Hoffmann et al.
Am. J. Clin. Nutr. 2004;80:633-640.
ABSTRACT | FULL TEXT  

Low cholesterol, mortality, and quality of life in old age during a 39-year follow-up
Strandberg et al.
J Am Coll Cardiol 2004;44:1002-1008.
ABSTRACT | FULL TEXT  

Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China
He et al.
Circulation 2004;110:405-411.
ABSTRACT | FULL TEXT  

Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normal
O'Keefe et al.
J Am Coll Cardiol 2004;43:2142-2146.
ABSTRACT | FULL TEXT  

Hypercholesterolemia inhibits L-type calcium current in coronary macro-, not microcirculation
Bowles et al.
J. Appl. Physiol. 2004;96:2240-2248.
ABSTRACT | FULL TEXT  

The Hunter-Gatherer Diet-Reply-I
Cordain and O'Keefe
Mayo Clin Proc. 2004;79:703-707.
 

If Suicide Is a Public Health Problem, What Are We Doing to Prevent It?
Knox et al.
AJPH 2004;94:37-45.
ABSTRACT | FULL TEXT  

Favorable Cardiovascular Risk Profile in Middle Age and Health-Related Quality of Life in Older Age
Daviglus et al.
Arch Intern Med 2003;163:2460-2468.
ABSTRACT | FULL TEXT  

Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
Raitakari et al.
JAMA 2003;290:2277-2283.
ABSTRACT | FULL TEXT  

Lifetime Risk of Coronary Heart Disease by Cholesterol Levels at Selected Ages
Lloyd-Jones et al.
Arch Intern Med 2003;163:1966-1972.
ABSTRACT | FULL TEXT  

Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk
Chu et al.
Hum Reprod 2003;18:1570-1573.
ABSTRACT | FULL TEXT  

Cholesterol, coronary heart disease, and stroke in the Asia Pacific region
Asia Pacific Cohort Studies Collaboration
Int J Epidemiol 2003;32:563-572.
ABSTRACT | FULL TEXT  

Pharmacological management of hyperlipidaemia
Evans et al.
British Journal of Diabetes & Vascular Disease 2003;3:204-210.
ABSTRACT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands
Marang-van de Mheen et al.
Eur Heart J 2002;23:1922-1930.
ABSTRACT  

The management of special patient populations
Deanfield
Eur Heart J Suppl 2002;4:F19-F23.
ABSTRACT  

A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men
Matvienko et al.
Am. J. Clin. Nutr. 2002;76:57-64.
ABSTRACT | FULL TEXT  

Is atherosclerosis accelerated in young patients with end-stage renal disease? The contribution of paediatric nephrology
Querfeld
Nephrol Dial Transplant 2002;17:719-722.
FULL TEXT  

Cholesterol absorption inhibition: filling an unmet need in lipid-lowering management
Leitersdorf
Eur Heart J Suppl 2001;3:E17-E23.
ABSTRACT  

Updated Guidelines for Cholesterol Management
Lauer and Fontanarosa
JAMA 2001;285:2508-2509.
FULL TEXT  

Pay Attention to Cholesterol in Young Men
JWatch General 2000;2000:2-2.
FULL TEXT  

Early Detection of High Cholesterol Levels in Young Adults
Grundy
JAMA 2000;284:365-367.
FULL TEXT